SE9701161D0 - New use I - Google Patents

New use I

Info

Publication number
SE9701161D0
SE9701161D0 SE9701161A SE9701161A SE9701161D0 SE 9701161 D0 SE9701161 D0 SE 9701161D0 SE 9701161 A SE9701161 A SE 9701161A SE 9701161 A SE9701161 A SE 9701161A SE 9701161 D0 SE9701161 D0 SE 9701161D0
Authority
SE
Sweden
Prior art keywords
oxytocin
new use
oestrogen
colic
navel
Prior art date
Application number
SE9701161A
Other languages
English (en)
Inventor
Goesta Alfven
Thomas Lundeberg
Moberg Kerstin Uvnaes
Original Assignee
Karolinska Innovations Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karolinska Innovations Ab filed Critical Karolinska Innovations Ab
Priority to SE9701161A priority Critical patent/SE9701161D0/sv
Publication of SE9701161D0 publication Critical patent/SE9701161D0/sv
Priority to AU67549/98A priority patent/AU749357B2/en
Priority to PCT/SE1998/000553 priority patent/WO1998043660A1/en
Priority to EP98912861A priority patent/EP1027067B1/en
Priority to ES98912861T priority patent/ES2231975T3/es
Priority to DE69826023T priority patent/DE69826023T2/de
Priority to AT98912861T priority patent/ATE274916T1/de
Priority to JP54154698A priority patent/JP2001527537A/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
SE9701161A 1997-03-27 1997-03-27 New use I SE9701161D0 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE9701161A SE9701161D0 (sv) 1997-03-27 1997-03-27 New use I
AU67549/98A AU749357B2 (en) 1997-03-27 1998-03-26 Use of substances having oxytocin activity for preparation of medicaments for the treatment of affective pain syndromes
PCT/SE1998/000553 WO1998043660A1 (en) 1997-03-27 1998-03-26 Use of substances having oxytocin activity for preparation of medicaments for the treatment of affective pain syndromes
EP98912861A EP1027067B1 (en) 1997-03-27 1998-03-26 Use of substances having oxytocin activity for the preparation of medicaments for the treatment of affective pain syndromes
ES98912861T ES2231975T3 (es) 1997-03-27 1998-03-26 Utilizacion de substancias con actividad oxitocica para la preparacion de medicamentos destinados para el tratamiento de sindromes dolorosos psicosomaticos.
DE69826023T DE69826023T2 (de) 1997-03-27 1998-03-26 Verwendung von Substanzen mit Oxytocinwirkung zur Herstellung eines Arzneimittels zur Behandlung affektiver Schmerzsyndrome
AT98912861T ATE274916T1 (de) 1997-03-27 1998-03-26 Verwendung von substanzen mit oxytocinwirkung zur herstellung eines arzneimittels zur behandlung affektiver schmerzsyndrome
JP54154698A JP2001527537A (ja) 1997-03-27 1998-03-26 情動性の痛み（ａｆｆｅｃｔｉｖｅ ｐａｉｎ）症候群治療用の医薬の製造のためのオキシトシン活性を有する物質の使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9701161A SE9701161D0 (sv) 1997-03-27 1997-03-27 New use I

Publications (1)

Publication Number Publication Date
SE9701161D0 true SE9701161D0 (sv) 1997-03-27

Family

ID=20406368

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9701161A SE9701161D0 (sv) 1997-03-27 1997-03-27 New use I

Country Status (8)

Country Link
EP (1) EP1027067B1 (sv)
JP (1) JP2001527537A (sv)
AT (1) ATE274916T1 (sv)
AU (1) AU749357B2 (sv)
DE (1) DE69826023T2 (sv)
ES (1) ES2231975T3 (sv)
SE (1) SE9701161D0 (sv)
WO (1) WO1998043660A1 (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9701162D0 (sv) * 1997-03-27 1997-03-27 Karolinska Innovations Ab New use II
SE9701184D0 (sv) * 1997-04-01 1997-04-01 Karolinska Innovations Ab Substanser för att åstadkomma preferens och skapa acceptans
DE1240180T1 (de) * 1999-12-21 2003-08-14 Innogenetics Nv Peptide zur diagnose und behandlung rheumatischer arthritis
SE0100684D0 (sv) * 2001-02-28 2001-02-28 Kerstin Uvnaes Moberg New subject-matter
CA2500831A1 (en) * 2002-10-03 2004-04-15 Eric Hollander Treatment of autism and similar disorders
DE10303672A1 (de) * 2003-01-24 2004-08-05 Beier, Klaus M., Prof. Dr.med. Dr.phil. Verwendung eines Neuropeptide und Steroide enthaltenden Gemisches zur Behandlung von Störungen des psychosozialen Erlebens und Verhaltens
ES2315455T3 (es) * 2003-03-27 2009-04-01 Pantarhei Bioscience B.V. Uso de estrogenos para el tratamiento de infertilidad en maniferos machos.
CA2516107C (en) 2003-04-10 2013-12-24 Ehud Zeigerson A method for production of emulsion-based microparticles
ES2625343T3 (es) * 2003-07-15 2017-07-19 Evonik Corporation Método para la preparación de formulaciones de liberación controlada
JP5165240B2 (ja) 2003-07-23 2013-03-21 ピーアール ファーマシューティカルズ， インコーポレイテッド 徐放組成物
JO2937B1 (en) 2004-08-11 2016-03-15 فيرينغ.بي.في Tight muscles of the peptide vascular tensioner receptor
CA2620202C (en) 2005-08-26 2016-10-04 The Board Of Trustees Of The Leland Stanford Junior University Therapy procedure for drug delivery for trigeminal pain
JP5185830B2 (ja) 2006-02-10 2013-04-17 フェリング ベスローテン フェンノートシャップ 新規化合物
EP2175874A2 (en) 2007-08-14 2010-04-21 Ferring B.V. Use of peptidic vasopressin receptor agonists
FR2954167A1 (fr) 2009-09-04 2011-06-24 Centre Nat Rech Scient Traitement par l'ocytocine de caracteristiques comportementales associees a l'autisme et a la timidite pathologique
SE536091C2 (sv) 2011-04-14 2013-04-30 Pep Tonic Medical Ab Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
EP4331670A2 (en) 2015-01-07 2024-03-06 Tonix Pharma Limited Magnesium-containing oxytocin formulations and methods of use
KR102193195B1 (ko) * 2018-10-24 2020-12-28 국립해양생물자원관 낙지 옥토프레신 활성 펩타이드 및 이의 용도
US11459355B2 (en) 2018-10-24 2022-10-04 National Marine Biodiversity Institute Of Korea Peptides having octopus octopressin activity and use thereof
WO2021024855A1 (ja) * 2019-08-02 2021-02-11 帝人ファーマ株式会社 線維筋痛症の治療薬又は予防薬

Also Published As

Publication number Publication date
EP1027067B1 (en) 2004-09-01
DE69826023T2 (de) 2005-09-08
AU6754998A (en) 1998-10-22
EP1027067A1 (en) 2000-08-16
ES2231975T3 (es) 2005-05-16
ATE274916T1 (de) 2004-09-15
JP2001527537A (ja) 2001-12-25
AU749357B2 (en) 2002-06-27
DE69826023D1 (de) 2004-10-07
WO1998043660A1 (en) 1998-10-08

Similar Documents

Publication Publication Date Title
SE9701161D0 (sv) New use I
SE9701162D0 (sv) New use II
DE59911740D1 (de) Topisch anwendbare mittel gegen nagelpilzerkrankungen
DE69230046T2 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
DE69531098D1 (de) Piperidine und pyrrolidine
NZ505742A (en) Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses
ES2083597T3 (es) Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado.
DK0832081T3 (da) Bicykliske-aromatiske forbindelser
MX9805705A (es) Compuestos biaromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ATE198467T1 (de) Diaromatische propynyl- oder dienylverbindungen
PT1001775E (pt) Medicamento contendo ioimbina e arginina para tratamento de disfuncao erectil
ZA971891B (en) Use of aryl N-substituted carboxamides directly and as radio- and chemosensitizers for killing tumor and cancer cells and novel compounds for such use
ATE275966T1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
ES2175006T3 (es) N-(pirimidinil)-benzosulfonamidas como medicamentos.
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
NO970185L (no) Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi
TR199901385T2 (xx) Piperidin t�revleri.
RU94024337A (ru) Антиметастатическое средство
ATE137968T1 (de) Verwendung von l-2-oxothiazolidine-4-carboxylate zur herstellung eines arzneimittels zur behandlung von latenten hiv-infektionen
WO1999003509A3 (de) Pharmazeutische mittel enthaltend perfluoralkylgruppenhaltige trijodaromaten und ihre verwendung in der tumortherapie und interventionellen radiologie
DK1150981T3 (da) Terapeutisk necleosidforbindelse
RU94039553A (ru) Средство для лечения хронического простатита
UA12937A (uk) Засіб для локальhого лікуваhhя гhійhо-запальhих раh та опіків, іhфіковаhих стафілококом